• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中间型年龄相关性黄斑变性和地理萎缩中按性别分层的白细胞介素 4 血浆水平。

Interleukin-4 Plasma Levels Stratified by Sex in Intermediate Age-Related Macular Degeneration and Geographic Atrophy.

机构信息

Department of Ophthalmology, University of Colorado School of Medicine, Aurora, CO, USA.

Colorado School of Public Health, University of Colorado School of Medicine, Aurora, CO, USA.

出版信息

Transl Vis Sci Technol. 2023 Aug 1;12(8):1. doi: 10.1167/tvst.12.8.1.

DOI:10.1167/tvst.12.8.1
PMID:37526620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10395651/
Abstract

PURPOSE

Chronic local inflammation underlies the pathogenesis of age-related macular degeneration (AMD) causing damage to the neurosensory retina. However, there is minimal research on systemic cell-mediated inflammation in AMD. Interleukin-4 (IL-4) is an immunoregulatory cytokine with an important role in modulating inflammation in chronic immune mediated disease. The purpose of this study was to: (1) investigate the role of systemic IL-4 in patients with intermediate AMD (iAMD) and in geographic atrophy (GA), an advanced form of AMD, compared to controls without AMD, and (2) determine if IL-4 levels are moderated by sex.

METHODS

We examined plasma levels of IL-4 in patients with iAMD, GA, and controls without AMD included in the University of Colorado AMD registry (August 2014 to June 2021). Cases and controls were defined by multimodal imaging. IL-4 was measured by multiplex immunoassay. Data were analyzed using a nonparametric rank based linear regression model fit to IL-4.

RESULTS

There were 199 patients with iAMD, 97 patients with GA, and 139 controls, with a percentage of female patients 61%, 55%, and 66%, respectively. We demonstrated significantly higher median IL-4 levels in GA (35.3; interquartile range [IQR] = 22.8-50.5) compared to iAMD (6.1; IQR = 2.2-11.3, P < 0.01) and controls (10.7; IQR = 5.0-16.8, P < 0.01). There were no significant differences in levels of IL-4 for cases and controls when stratified by sex.

CONCLUSIONS

These findings demonstrate a systemic immunological difference between iAMD and GA, indicating IL-4 may be a systemic biomarker for GA development.

TRANSLATIONAL RELEVANCE

The plasma biomarker IL-4 is significantly elevated in patients with GA.

摘要

目的

慢性局部炎症是年龄相关性黄斑变性(AMD)发病机制的基础,会对神经感觉视网膜造成损伤。然而,针对 AMD 患者系统性细胞介导炎症的研究甚少。白细胞介素-4(IL-4)是一种免疫调节细胞因子,在调节慢性免疫介导疾病的炎症方面发挥着重要作用。本研究的目的是:(1)研究系统性 IL-4 在中间型 AMD(iAMD)和地理萎缩(GA)患者中的作用,GA 是 AMD 的一种晚期形式,并与无 AMD 的对照组进行比较;(2)确定 IL-4 水平是否受性别调节。

方法

我们检测了科罗拉多大学 AMD 注册中心(2014 年 8 月至 2021 年 6 月)中 iAMD、GA 患者和无 AMD 对照组的血浆 IL-4 水平。病例和对照通过多模态成像定义。通过多重免疫测定法测量 IL-4。使用非参数基于秩的线性回归模型对 IL-4 进行数据分析。

结果

共有 199 名 iAMD 患者、97 名 GA 患者和 139 名对照,女性患者的百分比分别为 61%、55%和 66%。与 iAMD(6.1;IQR=2.2-11.3,P<0.01)和对照组(10.7;IQR=5.0-16.8,P<0.01)相比,GA 患者的中位 IL-4 水平明显更高(35.3;IQR=22.8-50.5)。按性别分层时,病例和对照之间的 IL-4 水平没有差异。

结论

这些发现表明 iAMD 和 GA 之间存在系统性免疫学差异,表明 IL-4 可能是 GA 发展的系统性生物标志物。

翻译后注释

  • 英文原文中的 AMD 指的是 age-related macular degeneration,中文译文统一翻译为“年龄相关性黄斑变性”。

  • 英文原文中的 iAMD 指的是 intermediate AMD,中文译文统一翻译为“中间型 AMD”。

  • 英文原文中的 GA 指的是 geographic atrophy,中文译文统一翻译为“地理萎缩”。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64af/10395651/01d1be627586/tvst-12-8-1-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64af/10395651/01d1be627586/tvst-12-8-1-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64af/10395651/01d1be627586/tvst-12-8-1-f001.jpg

相似文献

1
Interleukin-4 Plasma Levels Stratified by Sex in Intermediate Age-Related Macular Degeneration and Geographic Atrophy.中间型年龄相关性黄斑变性和地理萎缩中按性别分层的白细胞介素 4 血浆水平。
Transl Vis Sci Technol. 2023 Aug 1;12(8):1. doi: 10.1167/tvst.12.8.1.
2
Elevated tumor necrosis factor alpha and vascular endothelial growth factor in intermediate age-related macular degeneration and geographic atrophy.中年年龄相关性黄斑变性和地图样萎缩中肿瘤坏死因子α及血管内皮生长因子水平升高。
Front Ophthalmol (Lausanne). 2024 Mar 26;4:1356957. doi: 10.3389/fopht.2024.1356957. eCollection 2024.
3
RANTES (CCL5) in Patients With Geographic Atrophy Age-Related Macular Degeneration.RANTES(CCL5)在年龄相关性黄斑变性的地理萎缩患者中的表达。
Transl Vis Sci Technol. 2023 Jan 3;12(1):19. doi: 10.1167/tvst.12.1.19.
4
Sex Differences in RANTES (CCL5) in Patients With Intermediate Age-Related Macular Degeneration (AMD) and Controls With no AMD.中间年龄相关性黄斑变性(AMD)患者和无 AMD 对照者中 RANTES(CCL5)的性别差异。
Transl Vis Sci Technol. 2022 Feb 1;11(2):12. doi: 10.1167/tvst.11.2.12.
5
Systemic Levels of Interleukin-6 Correlate With Progression Rate of Geographic Atrophy Secondary to Age-Related Macular Degeneration.系统性白细胞介素-6 水平与年龄相关性黄斑变性继发地图状萎缩的进展速度相关。
Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):202-208. doi: 10.1167/iovs.18-25878.
6
Prognostic value of intermediate age-related macular degeneration phenotypes for geographic atrophy progression.中间型年龄相关性黄斑变性表型对地理萎缩进展的预后价值。
Br J Ophthalmol. 2021 Feb;105(2):239-245. doi: 10.1136/bjophthalmol-2020-316004. Epub 2020 Apr 8.
7
Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 5.年龄相关性黄斑变性中与进展为地图样萎缩相关的影像学特征:萎缩会议报告5分类
Ophthalmol Retina. 2021 Sep;5(9):855-867. doi: 10.1016/j.oret.2020.12.009. Epub 2020 Dec 22.
8
Characterizing the Journey of Geographic Atrophy Patients in Routine Ophthalmic Practice.描述在常规眼科实践中地理萎缩患者的治疗历程。
Ophthalmic Surg Lasers Imaging Retina. 2024 Apr;55(4):204-210. doi: 10.3928/23258160-20240123-02. Epub 2024 Feb 1.
9
Progression of Photoreceptor Degeneration in Geographic Atrophy Secondary to Age-related Macular Degeneration.年龄相关性黄斑变性继发地图状萎缩中感光细胞变性的进展。
JAMA Ophthalmol. 2020 Oct 1;138(10):1026-1034. doi: 10.1001/jamaophthalmol.2020.2914.
10
Sex and Age-Related Differences in Complement Factors Among Patients With Intermediate Age-Related Macular Degeneration.性别和年龄相关差异在中间年龄相关性黄斑变性患者补体因子。
Transl Vis Sci Technol. 2022 May 2;11(5):22. doi: 10.1167/tvst.11.5.22.

引用本文的文献

1
Proteomic profiles in the aqueous following anti-vegf therapy in treatment naïve neovascular age-related macular degeneration.初治新生血管性年龄相关性黄斑变性患者抗VEGF治疗后房水中的蛋白质组学特征
Clin Proteomics. 2025 Sep 1;22(1):32. doi: 10.1186/s12014-025-09555-3.
2
Dynamic Risk of Systemic Complement Activation With Time to Progression to Advanced Age-Related Macular Degeneration.随着进展至晚期年龄相关性黄斑变性的时间推移,系统性补体激活的动态风险
JAMA Ophthalmol. 2025 Jun 12. doi: 10.1001/jamaophthalmol.2025.1608.
3
Multimodal imaging biomarkers for progression from intermediate to advanced age-related macular degeneration (AMD): a 10-year prospective longitudinal cohort study from the University of Colorado AMD registry.

本文引用的文献

1
Serum levels of IL-4, IL-13 and IL-33 in patients with age-related macular degeneration and myeloproliferative neoplasms.血清中白细胞介素-4、白细胞介素-13 和白细胞介素-33 在年龄相关性黄斑变性和骨髓增生性肿瘤患者中的水平。
Sci Rep. 2023 Mar 11;13(1):4077. doi: 10.1038/s41598-023-31078-w.
2
RANTES (CCL5) in Patients With Geographic Atrophy Age-Related Macular Degeneration.RANTES(CCL5)在年龄相关性黄斑变性的地理萎缩患者中的表达。
Transl Vis Sci Technol. 2023 Jan 3;12(1):19. doi: 10.1167/tvst.12.1.19.
3
Investigational drugs in clinical trials for macular degeneration.
用于从中度到重度年龄相关性黄斑变性(AMD)进展的多模态成像生物标志物:一项来自科罗拉多大学AMD登记处的10年前瞻性纵向队列研究。
BMJ Open Ophthalmol. 2025 Apr 5;10(1):e002112. doi: 10.1136/bmjophth-2024-002112.
4
Peripheral blood age-sensitive immune markers in multiple sclerosis: relation to sex, cytomegalovirus status, and treatment.多发性硬化症患者外周血年龄敏感性免疫标志物:与性别、巨细胞病毒状态及治疗的关系
EBioMedicine. 2025 Feb;112:105559. doi: 10.1016/j.ebiom.2025.105559. Epub 2025 Jan 20.
5
Association Between Quantitative and Qualitative Imaging Biomarkers and Geographic Atrophy Growth Rate.定量和定性成像生物标志物与地图状萎缩生长速率之间的关联
Am J Ophthalmol. 2024 Aug;264:168-177. doi: 10.1016/j.ajo.2024.03.023. Epub 2024 Mar 27.
用于治疗年龄相关性黄斑变性的临床试验中的研究性药物。
Expert Opin Investig Drugs. 2022 Oct;31(10):1067-1085. doi: 10.1080/13543784.2022.2113375. Epub 2022 Sep 20.
4
Sex and Age-Related Differences in Complement Factors Among Patients With Intermediate Age-Related Macular Degeneration.性别和年龄相关差异在中间年龄相关性黄斑变性患者补体因子。
Transl Vis Sci Technol. 2022 May 2;11(5):22. doi: 10.1167/tvst.11.5.22.
5
Sex Differences in RANTES (CCL5) in Patients With Intermediate Age-Related Macular Degeneration (AMD) and Controls With no AMD.中间年龄相关性黄斑变性(AMD)患者和无 AMD 对照者中 RANTES(CCL5)的性别差异。
Transl Vis Sci Technol. 2022 Feb 1;11(2):12. doi: 10.1167/tvst.11.2.12.
6
Association of elevated plasma inflammatory biomarker levels with age-related macular degeneration but not cataract in persons with AIDS.血浆炎症生物标志物水平升高与艾滋病患者年龄相关性黄斑变性相关,但与白内障无关。
AIDS. 2022 Feb 1;36(2):177-184. doi: 10.1097/QAD.0000000000003104.
7
Plasma C-C Chemokine Concentrations in Intermediate Age-Related Macular Degeneration.中年相关性黄斑变性患者血浆C-C趋化因子浓度
Front Med (Lausanne). 2021 Nov 18;8:710595. doi: 10.3389/fmed.2021.710595. eCollection 2021.
8
Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis.白细胞介素 (IL)-4 和 IL-13 在炎症性关节炎中的意义。
Cells. 2021 Nov 3;10(11):3000. doi: 10.3390/cells10113000.
9
Sex differences in biological aging with a focus on human studies.性别差异与生物学衰老研究——以人类研究为例。
Elife. 2021 May 13;10:e63425. doi: 10.7554/eLife.63425.
10
Association of Systemic Inflammatory Factors with Progression to Advanced Age-related Macular Degeneration.全身性炎症因子与进展为晚期年龄相关性黄斑变性的相关性。
Ophthalmic Epidemiol. 2022 Apr;29(2):139-148. doi: 10.1080/09286586.2021.1910314. Epub 2021 Apr 8.